Cite

HARVARD Citation

    Liu, H. et al. (2017). The dipeptidyl peptidase-4 inhibitor teneligliptin reduces kidney damage from hypercholesterolemia in apolipoprotein E-deficient mice. RSC advances. 7 (14), pp. 8702-8708. [Online]. 
  
Back to record